000170916412/312024Q2FALSEhttp://fasb.org/us-gaap/2024#AccountsPayableCurrenthttp://fasb.org/us-gaap/2024#AccountsPayableCurrenthttp://fasb.org/us-gaap/2024#AccountsPayableCurrentP1Y5050xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purehbb:numberOfSiteiso4217:EUR00017091642024-01-012024-06-300001709164us-gaap:CommonClassAMember2024-07-260001709164us-gaap:CommonClassBMember2024-07-2600017091642024-06-3000017091642023-12-3100017091642023-06-300001709164us-gaap:CommonClassAMember2024-06-300001709164us-gaap:CommonClassAMember2023-12-310001709164us-gaap:CommonClassAMember2023-06-300001709164us-gaap:CommonClassBMember2024-06-300001709164us-gaap:CommonClassBMember2023-12-310001709164us-gaap:CommonClassBMember2023-06-3000017091642024-04-012024-06-3000017091642023-04-012023-06-3000017091642023-01-012023-06-3000017091642022-12-310001709164us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-12-310001709164us-gaap:CommonClassBMemberus-gaap:CommonStockMember2023-12-310001709164us-gaap:AdditionalPaidInCapitalMember2023-12-310001709164us-gaap:TreasuryStockCommonMember2023-12-310001709164us-gaap:RetainedEarningsMember2023-12-310001709164us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001709164us-gaap:RetainedEarningsMember2024-01-012024-03-3100017091642024-01-012024-03-310001709164us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001709164us-gaap:CommonClassAMemberus-gaap:CommonStockMember2024-01-012024-03-310001709164us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001709164us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001709164us-gaap:CommonClassAMemberus-gaap:CommonStockMember2024-03-310001709164us-gaap:CommonClassBMemberus-gaap:CommonStockMember2024-03-310001709164us-gaap:AdditionalPaidInCapitalMember2024-03-310001709164us-gaap:TreasuryStockCommonMember2024-03-310001709164us-gaap:RetainedEarningsMember2024-03-310001709164us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-3100017091642024-03-310001709164us-gaap:RetainedEarningsMember2024-04-012024-06-300001709164us-gaap:TreasuryStockCommonMember2024-04-012024-06-300001709164us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001709164us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001709164us-gaap:CommonClassAMemberus-gaap:CommonStockMember2024-06-300001709164us-gaap:CommonClassBMemberus-gaap:CommonStockMember2024-06-300001709164us-gaap:AdditionalPaidInCapitalMember2024-06-300001709164us-gaap:TreasuryStockCommonMember2024-06-300001709164us-gaap:RetainedEarningsMember2024-06-300001709164us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001709164us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-12-310001709164us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-12-310001709164us-gaap:AdditionalPaidInCapitalMember2022-12-310001709164us-gaap:TreasuryStockCommonMember2022-12-310001709164us-gaap:RetainedEarningsMember2022-12-310001709164us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001709164us-gaap:RetainedEarningsMember2023-01-012023-03-3100017091642023-01-012023-03-310001709164us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-01-012023-03-310001709164us-gaap:CommonClassBMemberus-gaap:CommonStockMember2023-01-012023-03-310001709164us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001709164us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001709164us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-03-310001709164us-gaap:CommonClassBMemberus-gaap:CommonStockMember2023-03-310001709164us-gaap:AdditionalPaidInCapitalMember2023-03-310001709164us-gaap:TreasuryStockCommonMember2023-03-310001709164us-gaap:RetainedEarningsMember2023-03-310001709164us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-3100017091642023-03-310001709164us-gaap:RetainedEarningsMember2023-04-012023-06-300001709164us-gaap:TreasuryStockCommonMember2023-04-012023-06-300001709164us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001709164us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001709164us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-06-300001709164us-gaap:CommonClassBMemberus-gaap:CommonStockMember2023-06-300001709164us-gaap:AdditionalPaidInCapitalMember2023-06-300001709164us-gaap:TreasuryStockCommonMember2023-06-300001709164us-gaap:RetainedEarningsMember2023-06-300001709164us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001709164us-gaap:LetterOfCreditMemberhbb:HBBFacilityMember2024-06-300001709164srt:MaximumMember2024-06-3000017091642023-01-012023-12-310001709164us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001709164us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001709164us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001709164us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMember2024-06-300001709164us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMember2023-12-310001709164us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMember2023-06-300001709164us-gaap:FairValueMeasurementsRecurringMember2024-06-300001709164us-gaap:FairValueMeasurementsRecurringMember2023-12-310001709164us-gaap:FairValueMeasurementsRecurringMember2023-06-300001709164us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMember2024-06-300001709164us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMember2023-12-310001709164us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMember2023-06-300001709164us-gaap:CommonClassBMember2024-04-012024-06-300001709164us-gaap:CommonClassBMember2024-01-012024-06-300001709164us-gaap:CommonClassBMember2023-04-012023-06-300001709164us-gaap:CommonClassBMember2023-01-012023-06-300001709164us-gaap:CommonClassAMember2024-04-012024-06-300001709164us-gaap:CommonClassAMember2024-01-012024-06-300001709164us-gaap:CommonClassAMember2023-04-012023-06-300001709164us-gaap:CommonClassAMember2023-01-012023-06-300001709164hbb:IncentivePlanMemberus-gaap:CommonClassAMember2024-03-052024-03-050001709164us-gaap:CommonClassAMember2023-11-300001709164us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001709164us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310001709164us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001709164us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310001709164us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-03-310001709164us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310001709164us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310001709164us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-03-310001709164us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310001709164us-gaap:AccumulatedTranslationAdjustmentMember2024-04-012024-06-300001709164us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-04-012024-06-300001709164us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-04-012024-06-300001709164us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300001709164us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-06-300001709164us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-06-300001709164us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001709164us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001709164us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001709164us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310001709164us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310001709164us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310001709164us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310001709164us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310001709164us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310001709164us-gaap:AccumulatedTranslationAdjustmentMember2023-04-012023-06-300001709164us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-012023-06-300001709164us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-04-012023-06-300001709164us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001709164us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300001709164us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300001709164hbb:ElectricAppliancesMembersrt:MaximumMember2024-01-012024-06-300001709164us-gaap:ProductAndServiceOtherMembersrt:MinimumMember2024-01-012024-06-300001709164us-gaap:ProductAndServiceOtherMembersrt:MaximumMember2024-01-012024-06-300001709164hbb:ConsumerProductMembersrt:MaximumMember2024-01-012024-06-300001709164hbb:CommercialProductMembersrt:MaximumMember2024-01-012024-06-300001709164hbb:ConsumerProductMember2024-04-012024-06-300001709164hbb:ConsumerProductMember2023-04-012023-06-300001709164hbb:ConsumerProductMember2024-01-012024-06-300001709164hbb:ConsumerProductMember2023-01-012023-06-300001709164hbb:CommercialProductMember2024-04-012024-06-300001709164hbb:CommercialProductMember2023-04-012023-06-300001709164hbb:CommercialProductMember2024-01-012024-06-300001709164hbb:CommercialProductMember2023-01-012023-06-300001709164hbb:LicensingMember2024-04-012024-06-300001709164hbb:LicensingMember2023-04-012023-06-300001709164hbb:LicensingMember2024-01-012024-06-300001709164hbb:LicensingMember2023-01-012023-06-300001709164us-gaap:GeographicConcentrationRiskMemberhbb:CommercialProductMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2024-01-012024-06-300001709164us-gaap:GeographicConcentrationRiskMemberhbb:CommercialProductMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:NonUsMember2024-01-012024-06-300001709164srt:MinimumMember2024-06-300001709164hbb:HealthBeaconMember2024-02-022024-02-020001709164hbb:HealthBeaconMember2024-04-012024-06-300001709164hbb:HealthBeaconMember2024-01-012024-06-300001709164hbb:HealthBeaconMember2024-06-300001709164hbb:HealthBeaconMember2024-02-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 _______________________________________________________________________________________________________________________________________________________________________________________________________
FORM 10-Q
(Mark One)  
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period endedJune 30, 2024
or
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number: 001-38214
HAMILTON BEACH BRANDS HOLDING COMPANY
(Exact name of registrant as specified in its charter)
Delaware 31-1236686
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
4421 WATERFRONT DR.GLEN ALLENVA23060
(Address of principal executive offices)(Zip code)
(804)273-9777
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Common Stock, Par Value $0.01 Per ShareHBBNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.             Yes þ No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).                             Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer oAccelerated filer þNon-accelerated filer
o
 
Smaller reporting company Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No þ

Number of shares of Class A Common Stock outstanding as of July 26, 2024: 10,287,081
Number of shares of Class B Common Stock outstanding as of July 26, 2024: 3,609,973




HAMILTON BEACH BRANDS HOLDING COMPANY
TABLE OF CONTENTS
   Page Number
Part I.
FINANCIAL INFORMATION
 
 
Item 1
Financial Statements
 
 
 
Item 2
Item 3
Item 4
Part II.
OTHER INFORMATION
Item 1
Item 1A
Item 2
Item 3
Item 4
Item 5
Item 6
Exhibits



Part I
FINANCIAL INFORMATION
Item 1. Financial Statements

HAMILTON BEACH BRANDS HOLDING COMPANY
CONSOLIDATED BALANCE SHEETS
(Unaudited)
JUNE 30
2024
DECEMBER 31
2023
JUNE 30
2023
 (In thousands)
Assets  
Current assets
Cash and cash equivalents$37,213 $15,370 $2,071 
Trade receivables, net85,038 135,434 89,898 
Inventory130,197 126,554 137,224 
Prepaid expenses and other current assets12,544 9,457 13,793 
Total current assets264,992 286,815 242,986 
Property, plant and equipment, net35,395 27,401 27,241 
Right-of-use lease assets37,486 39,423 41,546 
Goodwill7,099 6,253 6,253 
Other intangible assets, net2,210 1,292 1,392 
Deferred income taxes2,005 2,581 2,853 
Deferred costs14,523 14,613 14,419 
Other non-current assets6,186 6,324 6,687 
Total assets$369,896 $384,702 $343,377 
Liabilities and stockholders’ equity  
Current liabilities
Accounts payable$96,452 $99,704 $84,098 
Revolving credit agreements50,000   
Accrued compensation8,244 14,948 7,729 
Accrued product returns6,338 6,232 5,605 
Lease liabilities5,838 6,155 6,088 
Other current liabilities10,773 12,549 11,980 
Total current liabilities177,645 139,588 115,500 
Revolving credit agreements 50,000 59,911 
Lease liabilities, non-current40,489 41,937 44,480 
Other long-term liabilities6,030 5,910 5,120 
Total liabilities224,164 237,435 225,011 
Stockholders’ equity  
Preferred stock, par value $0.01 per share
   
Class A Common stock114 112 111 
Class B Common stock36 36 36 
Capital in excess of par value73,483 70,401 66,765 
Treasury stock(16,552)(12,013)(9,514)
Retained earnings101,078 99,398 72,563 
Accumulated other comprehensive loss(12,427)(10,667)(11,595)
Total stockholders’ equity145,732 147,267 118,366 
Total liabilities and stockholders’ equity$369,896 $384,702 $343,377 

See notes to unaudited consolidated financial statements.
1

HAMILTON BEACH BRANDS HOLDING COMPANY
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 THREE MONTHS ENDED
JUNE 30
SIX MONTHS ENDED
JUNE 30
 2024 202320242023
 (In thousands, except per share data)(In thousands, except per share data)
Revenue$156,240 $137,109 $284,517 $265,361 
Cost of sales115,744 109,693 213,967 217,035 
Gross profit40,496 27,416 70,550 48,326 
Selling, general and administrative expenses30,397 26,640 61,344 52,559 
Amortization of intangible assets143 50 193 100 
Operating profit (loss)9,956 726 9,013 (4,333)
Interest expense, net115 773 271 2,042 
Other expense (income), net883 (271)1,056 (255)
Income (loss) before income taxes8,958 224 7,686 (6,120)
Income tax expense (benefit)2,972 114 2,862 (1,453)
Net income (loss)$5,986 $110 $4,824 $(4,667)
   
Basic and diluted earnings (loss) per share$0.42 $0.01 $0.34 $(0.33)
Basic weighted average shares outstanding14,113 14,081 14,137 14,077 
Diluted weighted average shares outstanding14,127 14,110 14,152 14,077 

See notes to unaudited consolidated financial statements.
2

HAMILTON BEACH BRANDS HOLDING COMPANY
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
 THREE MONTHS ENDED
JUNE 30
SIX MONTHS ENDED
JUNE 30
 2024 202320242023
 (In thousands)(In thousands)
Net income (loss)$5,986 $110 $4,824 $(4,667)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment(1,868)410 (2,965)479 
(Loss) gain on long-term intra-entity foreign currency transactions 201  653 
Cash flow hedging activity1,555 (25)1,592 (1,462)
Reclassification of hedging activities into earnings(991)342 (519)529 
Reclassification of pension adjustments into earnings61 60 132 124 
Total other comprehensive income (loss), net of tax(1,243)988 (1,760)323 
Comprehensive income (loss)$4,743  $1,098 $3,064 $(4,344)

See notes to unaudited consolidated financial statements.

3

HAMILTON BEACH BRANDS HOLDING COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 SIX MONTHS ENDED
JUNE 30
 2024 2023
 (In thousands)
Operating activities   
Net income (loss)$4,824  $(4,667)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:   
Depreciation and amortization2,628  2,128 
Stock compensation expense3,084 1,759 
Other1,610  (611)
Net changes in operating assets and liabilities:   
Trade receivables49,582  26,393 
Inventory(7,657) 20,390 
Other assets(2,622) 396 
Accounts payable(3,076) 22,240 
Other liabilities(11,302) (10,768)
Net cash provided by (used for) operating activities 37,071  57,260 
Investing activities   
Expenditures for property, plant and equipment(1,540) (1,486)
Acquisition of business, net of cash acquired(7,412) 
Issuance of secured loan(600) 
Repayment of secured loan2,205  
Other (150)
Net cash provided by (used for) investing activities(7,347) (1,636)
Financing activities   
Net additions (reductions) to revolving credit agreements  (51,058)
Purchase of treasury stock(4,539)(575)
Cash dividends paid(3,144)(3,008)
Net cash provided by (used for) financing activities (7,683) (54,641)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(252) 182 
Cash, cash equivalents and restricted cash   
Increase (decrease) for the period21,789  1,165 
Balance at the beginning of the period16,379  1,905 
Balance at the end of the period$38,168  $3,070 
Reconciliation of cash, cash equivalents and restricted cash
Cash and cash equivalents$37,213 $2,071 
Restricted cash included in prepaid expenses and other current assets50 63 
Restricted cash included in other non-current assets905 936 
Total cash, cash equivalents and restricted cash$38,168 $3,070 

See notes to unaudited consolidated financial statements.
4

HAMILTON BEACH BRANDS HOLDING COMPANY
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Unaudited)
 Class A Common StockClass B Common StockCapital in Excess of Par ValueTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)Total Stockholders’ Equity
(In thousands, except per share data)
Balance, January 1, 2024$112 $36 $70,401 $(12,013)$99,398 $(10,667)$147,267 
Net income (loss)    (1,162) (1,162)
Purchase of treasury stock   (554)  (554)
Issuance of common stock, net of conversions2  (2)    
Share-based compensation expense  1,904    1,904 
Cash dividends, $0.11 per share
    (1,531) (1,531)
Other comprehensive income (loss), net of tax     (1,060)(1,060)
Reclassification adjustment to net income (loss)     543 543 
Balance, March 31, 2024114 36 72,303 (12,567)96,705 (11,184)145,407 
Net income (loss)    5,986  5,986 
Purchase of treasury stock   (3,985)  (3,985)
Share-based compensation expense  1,180    1,180 
Cash dividends, $0.115 per share
    (1,613) (1,613)
Other comprehensive income (loss), net of tax     (313)(313)
Reclassification adjustment to net income (loss)     (930)(930)
Balance, June 30, 2024$114 $36 $73,483 $(16,552)$101,078 $(12,427)$145,732 

Balance, January 1, 2023$107 $38 $65,008 $(8,939)$80,238 $(11,918)$124,534 
Net income (loss)— — — — (4,777)— (4,777)
Issuance of common stock, net of conversions4 (2)(2)— — —  
Share-based compensation expense— — 797 — — — 797 
Cash dividends, $0.105 per share
— — — — (1,460)— (1,460)
Other comprehensive income (loss), net of tax— — — — — (916)(916)
Reclassification adjustment to net income (loss)— — — — — 251 251 
Balance, March 31, 2023111 36 65,803 (8,939)74,001 (12,583)118,429 
Net income (loss)— — — — 110 — 110 
Purchase of treasury stock— — — (575)— — (575)
Share-based compensation expense— — 962 — — — 962 
Cash dividends, $0.11 per share
— — — — (1,548)— (1,548)
Other comprehensive income (loss), net of tax— — — — — 586 586 
Reclassification adjustment to net income (loss)— — — — — 402 402 
Balance, June 30, 2023$111 $36 $66,765 $(9,514)$72,563 $(11,595)$118,366 

See notes to unaudited consolidated financial statements.
5

HAMILTON BEACH BRANDS HOLDING COMPANY
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(Tabular amounts in thousands, except as noted and per share amounts)

NOTE 1—Basis of Presentation and Recently Issued Accounting Standards

Basis of Presentation

Throughout this Quarterly Report on Form 10-Q and the notes to unaudited consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”). HBB is the Company’s single reportable segment.

We are a leading designer, marketer and distributor of a wide range of branded small electric household and specialty housewares appliances, as well as commercial products for restaurants, fast food chains, bars and hotels, and are a provider of connected devices and software for healthcare management.

The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Operating results for the six months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the remainder of the year due to the highly seasonal nature of the Company’s primary markets. A majority of revenue and operating profit typically occurs in the second half of the calendar year when sales of products to retailers and consumers historically increase significantly for the fall holiday-selling season.

We maintain a $150.0 million senior secured floating-rate revolving credit facility (the “HBB Facility”) that expires on June 30, 2025, within one year after the issuance of these financial statements. Given the market conditions including unfavorable pricing terms, we have not yet completed our refinancing of the HBB Facility and accordingly, all amounts outstanding have been classified as current liabilities. Based on the current status of the refinancing and our history of successfully refinancing our debt, we believe that it is probable that the HBB Facility will be refinanced before its maturity. We believe funds available from cash on hand, the HBB Facility and operating cash flows will provide sufficient liquidity to meet our operating needs and commitments arising during the next twelve months.

Accounting Standards Not Yet Adopted

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which updates reportable segment disclosure requirements on an annual and interim basis. The amendments are effective for the annual period ending December 31, 2024, and the interim periods thereafter. Early adoption is permitted. Updates should be applied retrospectively to all prior periods presented in the financial statements. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which enhances income tax disclosure requirements primarily involving more detailed disclosure for income taxes paid and the effective tax rate reconciliation. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied prospectively but retrospective application is permitted. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows.




6

U.S. Pension Plan Termination

During 2022, the Board approved the termination of our U.S. defined benefit pension plan (the “Plan”) with an effective date of September 30, 2022. Benefit obligations under the Plan will be settled through a combination of lump sum payments to eligible plan participants and the purchase of a group annuity contract, under which future benefit obligations will be transferred to a third-party insurance company. The Company currently expects that all surplus assets remaining after the Plan termination will be transferred to a qualified replacement plan. The surplus assets as of December 31, 2023 were $12.2 million. The deferred loss of $6.5 million as of June 30, 2024 within Accumulated Other Comprehensive Income will be recognized fully when the plan is terminated or as settlements occur, which would trigger accelerated recognition. The termination process is expected to be completed in the third quarter of 2024.

Accounts payable - Supplier Finance Program

The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements. The agreement has a limit of $60.0 million in payment obligations ($85.0 million during peak season from August to January). There is no requirement to provide assets pledged as security or other forms of guarantees under the agreement. The Company pays the third-party administrator based upon the original payment terms negotiated with participating suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Consolidated Statement of Cash Flows. As of June 30, 2024, December 31, 2023 and June 30, 2023, the Company has $56.5 million, $55.0 million and $48.8 million, respectively, in outstanding payment obligations that are presented in Accounts payable on the Consolidated Balance Sheets. Of these totals, the third-party financial institution has made payments to participating suppliers to settle $48.0 million, $48.9 million and $44.9 million, respectively, of our outstanding payment obligations.

NOTE 2—Transfer of Financial Assets
The Company has entered into an arrangement with a financial institution to sell certain U.S. trade receivables on a non-recourse basis. Under the terms of the agreement, the Company receives cash proceeds and retains no rights or interest and has no obligations with respect to the sold receivables. These transactions, which are accounted for as sold receivables, result in a reduction in trade receivables because the agreement transfers effective control over and risk related to the receivables to the buyer. Under this arrangement, the Company derecognized $40.5 million and $70.6 million of trade receivables during the three and six months ending June 30, 2024, respectively, $29.6 million and $59.3 million of trade receivables during the three and six months ending June 30, 2023, respectively, and $128.7 million during the year ending December 31, 2023. The loss incurred on sold receivables in the consolidated results of operations for the three and six months ended June 30, 2024 and 2023 was not material. The Company does not carry any servicing assets or liabilities. Cash proceeds from this arrangement are reflected as operating activities in the Consolidated Statements of Cash Flows.

7

NOTE 3—Fair Value Disclosure

The following table presents the Company’s assets and liabilities accounted for at fair value on a recurring basis:
DescriptionBalance Sheet LocationJUNE 30
2024
 DECEMBER 31
2023
JUNE 30
2023
Assets:
Interest rate swap agreements
CurrentPrepaid expenses and other current assets$1,169 $511 $1,067 
Long-termOther non-current assets3,442 3,501 4,153 
Foreign currency exchange contracts
CurrentPrepaid expenses and other current assets325   
$4,936 $4,012 $5,220 
Liabilities:
Foreign currency exchange contracts
CurrentOther current liabilities 538 807 
$ $538 $807 

The Company measures its derivatives at fair value using significant observable inputs, which is Level 2 as defined in the fair value hierarchy. The Company uses a present value technique that incorporates the Secured Overnight Financing Rate (SOFR) swap curve, foreign currency spot rates and foreign currency forward rates to value its derivatives, including its interest rate swap agreements and foreign currency exchange contracts. The Company also incorporates the effect of HBB and counterparty credit risk into the valuation.

Other Fair Value Measurement Disclosures

The carrying amounts of cash and cash equivalents, trade receivables and accounts payable approximate fair value due to the short-term maturities of these instruments.

The $150.0 million fair value of the HBB Facility, including book overdrafts, which approximate book value, was determined using current rates offered for similar obligations taking into account the Company’s credit risk, which is Level 2 as defined in the fair value hierarchy.

There were no transfers into or out of Levels 1, 2 or 3 during the three and six months ended June 30, 2024.

8

NOTE 4—Stockholders’ Equity

Capital Stock 

The following table sets forth the Company’s authorized capital stock information:
JUNE 30
2024
DECEMBER 31
2023
JUNE 30
2023
Preferred stock, par value $0.01 per share
Preferred stock authorized5,000 5,000 5,000 
Preferred stock outstanding   
Class A Common stock, par value $0.01 per share
Class A Common authorized70,000 70,000 70,000 
Class A Common issued (1)(2)
11,442 11,161 11,094 
Treasury Stock (3)
1,127 877 683 
Class B Common stock, par value $0.01 per share, convertible into Class A Common stock on a one-for-one basis
Class B Common authorized30,000 30,000 30,000 
Class B Common issued (1)
3,611 3,616 3,629 

(1) Class B Common converted to Class A Common were 1 and 5 shares during the three and six months ending June 30, 2024, respectively, and 0 and 215 during the three and six months ending June 30, 2023, respectively.

(2) The Company issued Class A Common of 14 and 276 shares during the three and six months ending June 30, 2024, respectively, and 24 and 216 during the three and six months ending June 30, 2023, respectively.

(3) On March 5, 2024, a total of 30 mandatory cashless-exercise-award shares of Class A Common were surrendered to the Company by the participants of our Executive Long-Term Equity Incentive Compensation Plan (the “Incentive Plan”) in order to satisfy the participants’ tax withholding obligations with respect to shares of Class A Common awarded under the Incentive Plan on March 5, 2024.

Stock Repurchase Program: In November 2023, the Company’s Board approved a stock repurchase program for the purchase of up to $25 million of the Company’s Class A Common outstanding starting January 1, 2024 and ending December 31, 2025. This program replaced the previous stock repurchase plan that started February 22, 2022 and ended December 31, 2023. During the three and six months ended June 30, 2024, the Company repurchased 220,212 shares at prevailing market prices for an aggregate purchase price of $4.0 million. During the three and six months ended June 30, 2023, the Company repurchased 56,973 shares at prevailing market prices for an aggregate purchase price of $0.6 million. During the year ended December 31, 2023, the Company repurchased 250,772 shares for an aggregate purchase price of $3.1 million. As of June 30, 2024, the Company had $21.0 million remaining authorized for repurchase.

9

Accumulated Other Comprehensive Loss: The following table summarizes changes in accumulated other comprehensive loss by component and related tax effects for periods shown:
 Foreign CurrencyDeferred Gain (Loss) on Cash Flow Hedging Pension Plan AdjustmentTotal
Balance, January 1, 2024$(6,412)$2,424 $(6,679)$(10,667)
Other comprehensive income (loss)(1,097)29  (1,068)
Reclassification adjustment to net income (loss) 647 94 741 
Tax effects (167)(23)(190)
Balance, March 31, 2024(7,509)2,933 (6,608)(11,184)
Other comprehensive income (loss)(1,868)2,104  236 
Reclassification adjustment to net income (loss) (1,325)83 (1,242)
Tax effects (215)(22)(237)
Balance, June 30, 2024$(9,377)$3,497 $(6,547)$(12,427)
Balance, January 1, 2023$(8,924)$4,158 $(7,152)$(11,918)
Other comprehensive income (loss)715 (1,881) (1,166)
Reclassification adjustment to net income (loss) 252 87 339 
Tax effects(194)379 (23)162 
Balance, March 31, 2023(8,403)2,908 (7,088)(12,583)
Other comprehensive income (loss)425 (59) 366 
Reclassification adjustment to net income (loss) 465 83 548 
Tax effects186 (89)(23)74 
Balance, June 30, 2023$(7,792)$3,225 $(7,028)$(11,595)

NOTE 5—Revenue

Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services, which includes an estimate for variable consideration.

The Company’s warranty program to the consumer consists generally of an assurance-type limited warranty lasting for varying periods of up to ten years for electric appliances, with the majority of products having a warranty of one to three years. There is no guarantee to the consumer as the Company may repair or replace, in its discretion, products returned under warranty. Accordingly, the Company determined that no separate performance obligation exists.

Most of the Company’s products are not sold with a general right of return. Subject to certain terms and conditions, however, the Company will agree to accept a portion of products sold that, based on historical experience, are estimated to be returned for reasons such as product failure and excess inventory stocked by the customer. Product returns, customer programs and incentive offerings, including special pricing agreements, price competition, promotions and other volume-based incentives are accounted for as variable consideration.

10

A description of revenue sources and performance obligations for the Company are as follows:

Consumer and Commercial product revenue
Transactions with both consumer and commercial customers generally originate upon the receipt of a purchase order from a customer, which in some cases are governed by master sales agreements, specifying product(s) that the customer desires. Contracts for product revenue have an original duration of one year or less, and payment terms are generally standard and based on customer creditworthiness. Revenue from product sales is recognized at the point in time when control transfers to the customer, which is either when a product is shipped from a Company facility, or delivered to customers, depending on the shipping terms. The amount of revenue recognized varies primarily with price concessions and changes in returns. The Company offers price concessions to its customers for incentive offerings, special pricing agreements, price competition, promotions or other volume-based arrangements. The Company evaluated such agreements with its customers and determined returns and price concessions should be accounted for as variable consideration.

Consumer product revenue consists of sales of small electric household and specialty housewares appliances to traditional brick and mortar and ecommerce retailers, distributors and directly to the end consumer. A majority of this revenue is in North America.

Commercial product revenue consists of sales of products for restaurants, fast-food chains, bars and hotels. Approximately one-half of the Company’s commercial sales is in the U.S. and the other half is in markets across the globe.

License revenue
From time to time, the Company enters into exclusive and non-exclusive licensing agreements which grant the right to use certain of the Company’s intellectual property (“IP”) in connection with designing, manufacturing, distributing, advertising, promoting and selling the licensees’ products during the term of the agreement. The IP that is licensed generally consists of trademarks, trade names, patents, trade dress, logos and/or products (the “Licensed IP”). In exchange for granting the right to use the Licensed IP, the Company receives a royalty payment, which is a function of (1) the total net sales of products that use the Licensed IP and (2) the royalty percentage that is stated in the licensing agreement. The Company recognizes revenue at the later of when the subsequent sales occur or when the performance obligation is satisfied over time. Additionally, the Company enters into agreements which grant the right to use software for healthcare management. The Company receives a license payment which is recognized when the performance obligation is satisfied over time.

Lease revenue
The Company leases connected devices to specialty pharmacy networks and pharmaceutical companies and is accounted for under Accounting Standards Codification 842, Leases as operating leases.

The following table sets forth Company’s revenue on a disaggregated basis for the three and six months ended June 30:
THREE MONTHS ENDED
JUNE 30
SIX MONTHS ENDED
JUNE 30
 2024 202320242023
Type of good or service:
  Consumer products$139,785 $122,561 $252,535 $235,993 
  Commercial products14,420 13,671 27,873 27,075 
  Licensing1,345 877 2,960 2,293 
  Leasing690  1,149  
     Total revenues$156,240 $137,109 $284,517 $265,361 

NOTE 6—Contingencies

The Company is involved in various legal and regulatory proceedings and claims that have arisen in the ordinary course of business, including product liability, patent infringement, asbestos related claims, environmental and other claims. Although it is difficult to predict the ultimate outcome of these proceedings and claims, the Company believes the ultimate disposition of these matters will not have a material adverse effect on the financial condition, results of operation or cash flows of the Company. Any costs that the Company estimates will be paid as a result of these claims are accrued when the liability is considered probable and the amount of such costs can be reasonably estimated. If a range of amounts can be reasonably estimated and no amount within the range is a better estimate than any other amount, then the minimum of the range is accrued.
11

The Company does not accrue liabilities when the likelihood that the liability has been incurred is probable but the amount cannot be reasonably estimated or when the liability is believed to be only reasonably possible or remote. For contingencies where an unfavorable outcome is probable or reasonably possible and which are material, the Company discloses the nature of the contingency and, in some circumstances, an estimate of the possible loss.

Proceedings and claims asserted against the Company are subject to inherent uncertainties and unfavorable rulings could occur. If an unfavorable ruling were to occur, there exists the possibility of an adverse impact on the Company’s financial position and on the results of operations and cash flows for the period in which the ruling occurs, or in future periods.

Environmental matters

The Company is investigating or remediating historical environmental contamination at some current and former sites operated by the Company or by businesses it acquired. Based on the current stage of the investigation or remediation at each known site, the Company estimates the total investigation and remediation costs and the period of assessment and remediation activity required for each site. The estimate of future investigation and remediation costs is primarily based on variables associated with site clean-up, including, but not limited to, physical characteristics of the site, the nature and extent of the contamination and applicable regulatory programs and remediation standards.
No assessment can fully characterize all subsurface conditions at a site. There is no assurance that additional assessment and remediation efforts will not result in adjustments to estimated remediation costs or the time frame for remediation at these sites.

The Company’s estimates of investigation and remediation costs may change if it discovers contamination at additional sites or additional contamination at known sites, if the effectiveness of its current remediation efforts change, if applicable federal or state regulations change or if the Company’s estimate of the time required to remediate the sites changes. The Company’s current estimates may differ materially from original estimates.        

As of June 30, 2024, December 31, 2023 and June 30, 2023, the Company had accrued undiscounted obligations of $3.2 million, $3.4 million and $3.5 million, respectively, for environmental investigation and remediation activities. The Company estimates that it is reasonably possible that it may incur additional expenses in the range of zero to $1.5 million related to the environmental investigation and remediation at these sites. As of June 30, 2024, the Company has $1.0 million, classified as restricted cash, associated with reimbursement of environmental investigation and remediation costs from a responsible party in exchange for release from all future obligations for one site. Additionally, the Company has a $1.2 million asset associated with the reimbursement of costs associated with two sites.

NOTE 7—Income Taxes

The Company’s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period.

The effective tax rate was 33.2% and 50.9% on income for the three months ended June 30, 2024 and 2023, respectively. The effective tax rate was lower in the three months ended June 30, 2024 due to a decrease in unfavorable discrete items, partially offset by a valuation allowance on foreign losses.

The effective tax rate was 37.2% on income and 23.7% on loss for the six months ended June 30, 2024 and 2023, respectively. The effective tax rate was higher for the six months ended June 30, 2024 due to a valuation allowance on foreign losses subject to a foreign statutory rate lower than the US tax rate.


12

NOTE 8—Acquisitions

On February 2, 2024, we completed the acquisition of HealthBeacon PLC (“HealthBeacon”), a medical technology firm and strategic partner of the Company, for €6.9 million (approximately $7.5 million). The transaction was funded with cash on hand.

The acquisition of HealthBeacon was accounted for as a business combination using the acquisition method of accounting. The results of operations for HealthBeacon are included in the accompanying Consolidated Statements of Operations from the acquisition date (February 2, 2024) until June 30, 2024. HealthBeacon had $0.8 million and $1.4 million in revenue and $1.5 million and $2.6 million in operating loss that was included in our consolidated financial statements for the three and six months ended June 30, 2024, respectively. Pro forma financial information has not been presented, as revenue and expenses related to the acquisition do not have a material impact on the Company’s unaudited consolidated financial statements.

The determination and allocation of purchase price consideration is based on preliminary estimates of fair value; such estimates and assumptions are subject to change within the measurement period (up to one year from the acquisition date). As of June 30, 2024, the purchase price allocation for HealthBeacon is preliminary as we assess and gather additional information regarding the fair value of the assets acquired and liabilities assumed as of the acquisition date. We may revise our preliminary estimates during the measurement period as third-party valuations are finalized, additional information becomes available and as additional analyses are performed. These differences could have a material impact on our results of operations and financial position.

The valuations of property, plant and equipment and intangible assets were updated in the second quarter of 2024. Property, plant, and equipment decreased by $0.8 million and intangible assets decreased by less than $0.1 million resulting in $0.8 million of goodwill.

During the three and six months ended June 30, 2024, we incurred transaction costs of approximately $0.1 million and $1.1 million, respectively, which are included in Selling, general and administrative expenses.

The following table presents the preliminary value of assets acquired and liabilities assumed and will be finalized pending completion of purchase accounting matters:
Preliminary Fair Values as of
February 2, 2024
Cash and cash equivalents$147 
Current assets1,452 
Property, plant and equipment, net6,634 
Goodwill847 
Other intangible assets, net1,111 
Total assets acquired10,191 
Liabilities, current2,016 
Liabilities, non-current616 
Total liabilities acquired2,632 
Purchase Price$7,559 

Item 2. - Management’s Discussion and Analysis of Financial Condition and Results of Operations
(Dollars in thousands, except as noted and per share data)

Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon management’s current expectations and are subject to various uncertainties and changes in circumstances. Important factors that could cause actual results to differ materially from those described in these forward-looking statements are set forth below under the heading “Forward-Looking Statements.”
HBB is the Company’s single reportable segment.




13

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

For a summary of the Company’s critical accounting policies, refer to “Part II - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Estimates” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as there have been no material changes from those disclosed in the Annual Report.

RESULTS OF OPERATIONS

The Company’s business is seasonal, and a majority of revenue and operating profit typically occurs in the second half of the year when sales of small electric appliances and kitchenware historically increase significantly for the fall holiday-selling season.

Second Quarter of 2024 Compared with Second Quarter of 2023
THREE MONTHS ENDED
JUNE 30
Increase / (Decrease)
2024% of Revenue2023% of Revenue$ Change% Change
Revenue$156,240 100.0 %$137,109 100.0 %$19,131 14.0 %
Cost of sales115,744 74.1 %109,693 80.0 %6,051 5.5 %
Gross profit40,496 25.9 %27,416 20.0 %13,080 47.7 %
Selling, general and administrative expenses30,397 19.5 %26,640 19.4 %3,757 14.1 %
Amortization of intangible assets143 0.1 %50 — %93 186.0 %
Operating profit (loss)9,956 6.4 %726 0.5 %9,230 1,271.3 %
Interest expense, net115 0.1 %773 0.6 %(658)(85.1)%
Other expense (income), net883 0.6 %(271)(0.2)%1,154 (425.8)%
Income (loss) before income taxes8,958 5.7 %224 0.2 %8,734 3,899.1 %
Income tax expense (benefit)2,972 1.9 %114 0.1 %2,858 2,507.0 %
Net income (loss) $5,986 3.8 %$110 0.1 %$5,876 5,341.8 %
Effective income tax rate33.2 %50.9 %

The following table identifies the components of the change in revenue:
 Revenue
2023$137,109 
Increase (decrease) from:
Unit volume and product mix26,180 
Average sales price (7,265)
Foreign currency216 
2024$156,240 

Revenue - Revenue increased $19.1 million or 14.0% increase compared to the prior year due to increased unit volume and a more favorable product mix primarily driven by increased revenue in the US Consumer market. Additionally, sales increased in the Latin American and Mexican Consumer and Global Commercial markets, while sales decreased in the Canadian Consumer market.

Gross profit - As a percentage of revenue, gross profit margin increased to 25.9% compared to 20.0% in the prior year primarily due to lower product costs and a favorable product mix.

Selling, general and administrative expenses - Selling, general and administrative expenses increased by $3.8 million compared to the second quarter of 2023. The increase was primarily due to the addition of HealthBeacon’s selling, general and administrative expenses as well as overall increases in employee-related costs and advertising expenses.
14

Interest expense, net - Interest expense, net decreased $0.7 million due to decreased average borrowings outstanding under the HBB Facility and lower interest rates compared to the second quarter of 2023.

Other expense (income), net - Other expense (income), net includes currency losses of $0.6 million in the current year compared to currency gains of $0.4 million in the prior year.

Income tax expense (benefit) - The effective tax rate on income was 33.2% and 50.9% for three months ended June 30, 2024 and 2023, respectively. The effective tax rate was lower in the three months ended June 30, 2024 due to a decrease in unfavorable discrete items, partially offset by a valuation allowance on foreign losses.

First Six Months of 2024 Compared with First Six Months of 2023
SIX MONTHS ENDED
JUNE 30
2024% of Revenue2023% of Revenue$ Change% Change
Revenue$284,517 100.0 %$265,361 100.0 %$19,156 7.2 %
Cost of sales213,967 75.2 %217,035 81.8 %(3,068)(1.4)%
Gross profit70,550 24.8 %48,326 18.2 %22,224 46.0 %
Selling, general and administrative expenses61,344 21.6 %52,559 19.8 %8,785 16.7 %
Amortization of intangible assets193 0.1 %100 — %93 93.0 %
Operating profit (loss)9,013 3.2 %(4,333)(1.6)%13,346 (308.0)%
Interest expense, net271 0.1 %2,042 0.8 %(1,771)(86.7)%
Other expense (income), net1,056 0.4 %(255)(0.1)%1,311 (514.1)%
Income (loss) before income taxes7,686 2.7 %(6,120)(2.3)%13,806 (225.6)%
Income tax expense (benefit)2,862 1.0 %(1,453)(0.5)%4,315 (297.0)%
Net income (loss)$4,824 1.7 %$(4,667)(1.8)%$9,491 (203.4)%
Effective income tax rate37.2 %23.7 %

The following table identifies the components of the change in revenue:
 Revenue
2023$265,361 
Increase (decrease) from:
Unit volume and product mix38,340 
Average sales price(20,220)
Foreign currency1,036 
2024$284,517 

Revenue - Revenue increased by $19.2 million compared to the prior year due to increased unit volume and a more favorable product mix primarily driven by increased revenue in the US Consumer market. Additionally, sales increased in the Latin American and Mexican Consumer and Global Commercial markets, while sales decreased in the Canadian Consumer market.

Gross profit - Gross profit margin increased to 24.8% from 18.2% primarily due to lower product costs and a favorable product mix.

Selling, general and administrative expenses - Selling, general and administrative expenses increased $8.8 million compared to 2023. The increase was primarily due to the addition of HealthBeacon’s selling, general and administrative expenses along with $1.1 million of transaction costs, an increase in employee-related costs including non-cash stock incentive compensation due to stock price appreciation, and increased advertising expenses.

Interest expense, net - Interest expense, net decreased $1.8 million due to decreased average borrowings outstanding under the HBB Facility, and lower interest rates compared to 2023.

15

Other expense (income), net - Other expense (income), net includes currency losses of $0.7 million in the current year compared to currency gains of $0.5 million in the prior year.

Income tax expense (benefit) - The effective tax rate was 37.2% compared to 23.7% in the prior year. The effective tax rate was higher for the six months ended June 30, 2024 due to a valuation allowance on foreign losses subject to a foreign statutory rate lower than the US tax rate.
LIQUIDITY AND CAPITAL RESOURCES
Liquidity

Our cash flows are provided by dividends paid or distributions made by HBB. The only material assets held by us are the investments in our consolidated subsidiary. As a result, certain statutory limitations or regulatory or financing agreements could affect the levels of distributions allowed to be made by our subsidiary. We have not guaranteed any of the obligations of HBB.

Our principal sources of cash to fund liquidity needs are: (1) cash generated from operations and (2) borrowings available under the HBB Facility. Our primary use of funds consists of working capital requirements, operating expenses, payment of dividends, repurchase of shares, capital expenditures and payments of principal and interest on debt.

The HBB Facility expires on June 30, 2025, within one year after the issuance of these financial statements. Given the market conditions including unfavorable pricing terms, we have not yet completed our refinancing of the HBB Facility and accordingly, all amounts outstanding have been classified as current liabilities. Based on the current status of the refinancing and our history of successfully refinancing our debt, we believe that it is probable that the HBB Facility will be refinanced before its maturity. We believe funds available from cash on hand, the HBB Facility and operating cash flows will provide sufficient liquidity to meet our operating needs and commitments arising during the next twelve months.

The following table presents selected cash flow information:
SIX MONTHS ENDED
JUNE 30
 20242023
Net cash provided by (used for) operating activities$37,071 $57,260 
Net cash provided by (used for) investing activities$(7,347)$(1,636)
Net cash provided by (used for) financing activities$(7,683)$(54,641)

Operating activities - Net cash provided by operating activities was $37.1 million compared to $57.3 million in the prior year. Net working capital provided cash of $38.8 million in 2024 compared to cash provided of $69.0 million in 2023. The 2024 and 2023 periods benefited from a continued focus on collections initiatives that led to improvements in days sales outstanding (DSO). The 2023 period benefited from significant excess inventory reduction activities.

Investing activities - Net cash used for investing activities in 2024 increased compared to 2023 related primarily to the acquisition of HealthBeacon offset by the extinguishment of our secured loan to HealthBeacon in the first quarter of 2024 which provided net cash of $1.6 million.
Financing activities - Net cash used for financing activities was $7.7 million in 2024 compared to net cash used for financing activities of $54.6 million in 2023. The change is due to a decrease in HBB’s net borrowing activity on the HBB Facility.

Capital Resources

The HBB Facility expires on June 30, 2025. The entire outstanding balance has been classified as a current liability due to the fact the facility expires within one year and has not yet been refinanced. The Company does not expect to make voluntary repayments under the HBB Facility within the next twelve months as the rate of return to invest excess cash exceeds the average interest rate of the HBB Facility. A material decrease in interest rates could cause us to re-evaluate.

The obligations under the HBB Facility are secured by substantially all of HBB’s assets. As of June 30, 2024, the borrowing base under the HBB Facility was $124.2 million and borrowings outstanding were $50.0 million. As of June 30, 2024, the excess availability under the HBB Facility was $74.2 million.
16

The maximum availability under the HBB Facility is governed by a borrowing base derived from advance rates against eligible trade receivables, inventory and trademarks of the borrowers, as defined in the HBB Facility. Borrowings bear interest at a floating rate, which can be a base rate, SOFR or bankers’ acceptance rate, as defined in the HBB Facility, plus an applicable margin. The applicable margins, effective June 30, 2024, for base rate loans and SOFR loans denominated in U.S. dollars were 0.0% and 1.55%, respectively. The applicable margins, effective June 30, 2024, for base rate loans and bankers’ acceptance loans denominated in Canadian dollars were 0.0% and 1.55%, respectively. The HBB Facility also requires a fee of 0.25% per annum on the unused commitment. The margins and unused commitment fee under the HBB Facility are subject to quarterly adjustment based on average excess availability. The weighted average interest rate applicable to the HBB Facility for the six months ended June 30, 2024 was 3.17% including the floating rate margin and the effect of the interest rate swap agreements described below.

To reduce the exposure to changes in the market rate of interest, we have entered into interest rate swap agreements for a portion of the HBB Facility. Terms of the interest rate swap agreements require us to receive a variable interest rate and pay a fixed interest rate. We have interest rate swaps with notional values totaling $50.0 million as of June 30, 2024 at an average fixed interest rate of 1.59%.

The HBB Facility includes restrictive covenants, which, among other things, limit the payment of dividends, subject to achieving availability thresholds. Dividends are not to exceed $7.0 million during any calendar year to the extent that for the thirty days prior to the dividend payment date, and after giving effect to the dividend payment, HBB maintains excess availability of at least $18.0 million. Dividend amounts are discretionary to the extent that for the thirty days prior to the dividend payment date, and after giving effect to the dividend payment, HBB maintains excess availability of at least $30.0 million. The HBB Facility also requires the Company to achieve a minimum fixed charge coverage ratio in certain circumstances, as defined in the HBB Facility. As of June 30, 2024, we were in compliance with all financial covenants in the HBB Facility.
In December 2015, the Company entered into an arrangement with a financial institution to sell certain U.S. trade receivables on a non-recourse basis. See Note 2 of the unaudited consolidated financial statements.

Contractual Obligations, Contingent Liabilities and Commitments

For a summary of the Company’s contractual obligations, contingent liabilities and commitments, refer to “Part II - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Contractual Obligations, Contingent Liabilities and Commitments” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as there have been no material changes from those disclosed in the Annual Report.

Off Balance Sheet Arrangements

For a summary of the Company’s off balance sheet arrangements, refer to “Part II - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Off Balance Sheet Arrangements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as there have been no material changes from those disclosed in the Annual Report.

17

FORWARD-LOOKING STATEMENTS

The statements contained in this Form 10-Q that are not historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act. These forward-looking statements are made subject to certain risks and uncertainties, which could cause actual results to differ materially from those presented. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Such risks and uncertainties include, without limitation: (1) uncertain or unfavorable global economic conditions and impacts from global military conflicts; (2) the Company’s ability to source and ship products to meet anticipated demand; (3) the Company’s ability to successfully manage constraints throughout the global transportation supply chain; (4) changes in the sales prices, product mix or levels of consumer purchases of small electric and specialty housewares appliances; (5) changes in consumer retail and credit markets, including the increasing volume of transactions made through third-party internet sellers; (6) bankruptcy of or loss of major retail customers or suppliers; (7) changes in costs, including transportation costs, of sourced products; (8) delays in delivery of sourced products; (9) changes in or unavailability of quality or cost effective suppliers; (10) exchange rate fluctuations, changes in the import tariffs and monetary policies and other changes in the regulatory climate in the countries in which the Company operates or buys and/or sells products; (11) the impact of tariffs on customer purchasing patterns; (12) product liability, regulatory actions or other litigation, warranty claims or returns of products; (13) customer acceptance of, changes in costs of or delays in the development of new products; (14) increased competition, including consolidation within the industry; (15) changes in customers’ inventory management strategies; (16) shifts in consumer shopping patterns, gasoline prices, weather conditions, the level of consumer confidence and disposable income as a result of economic conditions, unemployment rates or other events or conditions that may adversely affect the level of customer purchases of the Company’s products; (17) changes mandated by federal, state and other regulation, including tax, health, safety or environmental legislation; (18) the Company’s ability to identify, acquire or develop, and successfully integrate, new businesses or new product lines; and (19) other risk factors, including those described in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the Annual Report on Form 10-K for the year ended December 31, 2023. Furthermore, the future impact of unfavorable economic conditions, including inflation, changing interest rates, availability of capital markets and consumer spending rates remains uncertain. In uncertain economic environments, we cannot predict whether or when such circumstances may improve or worsen, or what impact, if any, such circumstances could have on our business, results of operations, cash flows and financial position.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

INTEREST RATE RISK

We enter into certain financing arrangements that require interest payments based on floating interest rates. As such, our financial results are subject to changes in the market rate of interest. There is an inherent rollover risk for borrowings as they mature and are renewed at current market rates. The extent of this risk is not quantifiable or predictable because of the variability of future interest rates and business financing requirements. To reduce the exposure to changes in the market rate of interest, we have entered into interest rate swap agreements for a portion of our floating rate financing arrangements. We do not enter into interest rate swap agreements for trading purposes. Terms of the interest rate swap agreements require us to receive a variable interest rate and pay a fixed interest rate.

For the purpose of risk analysis, we use sensitivity analysis to measure the potential loss in fair value of financial instruments sensitive to changes in interest rates. We assume that a loss in fair value is an increase in our receivables. The fair value of the Company’s interest rate swap agreements was an asset of $4.6 million as of June 30, 2024. A hypothetical 10% relative decrease in interest rates would cause a decrease of $0.2 million in the fair value of interest rate swap agreements. Additionally, a hypothetical 10% relative increase in interest rates would cause an increase of $0.2 million in the fair value of interest rate swap agreements. Neither would have a material impact to the Company’s interest expense, net of $0.3 million for the six months ended June 30, 2024.

FOREIGN CURRENCY EXCHANGE RATE RISK

We operate internationally through our foreign operating subsidiaries and enters into transactions denominated in foreign currencies, principally the Canadian dollar, the Mexican peso and, to a lesser extent, the Chinese yuan, Brazilian real and the European Union euro. As such, our financial results are subject to the variability that arises from exchange rate movements. The fluctuation in the value of the U.S. dollar against other currencies affects the reported amounts of revenues, expenses, assets and liabilities. The potential impact of currency fluctuation increases as international expansion increases.

18

We use forward foreign currency exchange contracts to partially reduce risks related to transactions denominated in foreign currencies and not for trading purposes. These contracts generally mature within twelve months and require us to buy or sell the functional currency in which the applicable subsidiary operates and buy or sell U.S. dollars at rates agreed to at the inception of the contracts.

For the purpose of risk analysis, we use sensitivity analysis to measure the potential loss in fair value of financial instruments sensitive to changes in foreign currency exchange spot rates. We assume that a loss in fair value is either a decrease to our assets or an increase to our liabilities. The fair value of our foreign currency exchange contracts was a net receivable of $0.3 million as of June 30, 2024. Assuming a hypothetical 10% weakening of the U.S. dollar as of June 30, 2024, the fair value of foreign currency-sensitive financial instruments, which represents forward foreign currency exchange contracts, would be decreased by $1.6 million compared with its fair value as of June 30, 2024.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures
Company management, with the participation of the Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures as of June 30, 2024. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of June 30, 2024.
Changes in Internal Control Over Financial Reporting
There were no changes, except as noted below, in the Company’s internal control over financial reporting identified during the quarter ended June 30, 2024, in connection with the evaluation by the Company’s management required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
On February 2, 2024, we acquired HealthBeacon, as discussed in Note 8: Acquisition in Part I, Item 1 in this Quarterly Report on Form 10-Q. We are currently integrating HealthBeacon into our operations and internal control processes, and, as permitted by the SEC rules and regulations, we have not yet included HealthBeacon in our assessment of the effectiveness of our internal control over financial reporting. We anticipate HealthBeacon will be included in management’s evaluation of internal control over financial reporting as of December 31, 2025.
19

PART II
OTHER INFORMATION

Item 1    Legal Proceedings
The information required by this Item 1 is set forth in Note 6 “Contingencies” included in the unaudited consolidated financial statements contained in Part I of this Form 10-Q and is hereby incorporated herein by reference to such information.

Item 1A    Risk Factors
There are no material changes to the risk factors for the Company from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Item 2    Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities (1)
(a)(b)(c)(d)
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of the Publicly Announced ProgramMaximum Dollar Value of Shares that May Yet Be Purchased Under the Program
Month #1
April 1 to 30, 2024
— $— — $25,000,000 
Month #2
May 1 to 31, 2024
117,729 $18.46 117,729 $22,827,298 
Month #3
June 1 to 30, 2024
102,483 $17.68 102,483 $21,015,285 
220,212 $18.09 220,212 $21,015,285 

(1) In November 2023, the Company’s Board approved a stock repurchase program for the purchase of up to $25 million of the Company’s Class A Common outstanding starting January 1, 2024 and ending December 31, 2025.

During the three and six months ended June 30, 2024, the Company repurchased 220,212 shares at prevailing market prices for an aggregate purchase price of $4.0 million. During the three and six months ended June 30, 2023, the Company repurchased 56,973 shares at prevailing market prices for an aggregate purchase price of $0.6 million. During the year ended December 31, 2023, the Company repurchased 250,772 shares for an aggregate purchase price of $3.1 million.

Item 3    Defaults Upon Senior Securities
None.

Item 4    Mine Safety Disclosures
None.

Item 5    Other Information
None of the Company’s directors or "officers" (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, during the Company's fiscal quarter ended June 30, 2024.

20

Item 6    Exhibits
Exhibit  
Number* Description of Exhibits
3.1
10.1
10.2
31(i)(1) 
31(i)(2) 
32 
101.INS Inline XBRL Instance Document
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
*    Numbered in accordance with Item 601 of Regulation S-K.
21

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Hamilton Beach Brands Holding Company
(Registrant)
 
Date:July 31, 2024/s/ Sally M. Cunningham
 Sally M. Cunningham
 Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)/(Principal Accounting Officer)

22

Exhibit 31(i)(1)

Certifications

I, Gregory H. Trepp, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Hamilton Beach Brands Holding Company;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:July 31, 2024/s/ Gregory H. Trepp
Gregory H. Trepp
Chief Executive Officer (Principal Executive Officer)




Exhibit 31(i)(2)

Certifications

I, Sally M. Cunningham, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Hamilton Beach Brands Holding Company;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:July 31, 2024/s/ Sally M. Cunningham
Sally M. Cunningham
Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)/(Principal Accounting Officer)


Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hamilton Beach Holding Company (the “Company”) on Form 10-Q for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

Date:July 31, 2024/s/ Gregory H. Trepp
Gregory H. Trepp
Chief Executive Officer (Principal Executive Officer)
Date:July 31, 2024/s/ Sally M. Cunningham
Sally M. Cunningham
Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)/(Principal Accounting Officer)






v3.24.2
Cover Page - shares
6 Months Ended
Jun. 30, 2024
Jul. 26, 2024
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2024  
Document Transition Report false  
Entity File Number 001-38214  
Entity Registrant Name HAMILTON BEACH BRANDS HOLDING COMPANY  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 31-1236686  
Entity Address, Address Line One 4421 WATERFRONT DR.  
Entity Address, City or Town GLEN ALLEN  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 23060  
City Area Code (804)  
Local Phone Number 273-9777  
Title of 12(b) Security Class A Common Stock, Par Value $0.01 Per Share  
Trading Symbol HBB  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001709164  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Class A Common stock    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   10,287,081
Class B Common stock    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   3,609,973
v3.24.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2023
Current assets      
Cash and cash equivalents $ 37,213 $ 15,370 $ 2,071
Trade receivables, net 85,038 135,434 89,898
Inventory 130,197 126,554 137,224
Prepaid expenses and other current assets 12,544 9,457 13,793
Total current assets 264,992 286,815 242,986
Property, plant and equipment, net 35,395 27,401 27,241
Right-of-use lease assets 37,486 39,423 41,546
Goodwill 7,099 6,253 6,253
Other intangible assets, net 2,210 1,292 1,392
Deferred income taxes 2,005 2,581 2,853
Deferred costs 14,523 14,613 14,419
Other non-current assets 6,186 6,324 6,687
Total assets 369,896 384,702 343,377
Current liabilities      
Accounts payable 96,452 99,704 84,098
Revolving credit agreements 50,000 0 0
Accrued compensation 8,244 14,948 7,729
Accrued product returns 6,338 6,232 5,605
Lease liabilities 5,838 6,155 6,088
Other current liabilities 10,773 12,549 11,980
Total current liabilities 177,645 139,588 115,500
Revolving credit agreements 0 50,000 59,911
Lease liabilities, non-current 40,489 41,937 44,480
Other long-term liabilities 6,030 5,910 5,120
Total liabilities 224,164 237,435 225,011
Stockholders’ equity      
Preferred stock, par value $0.01 per share 0 0 0
Capital in excess of par value 73,483 70,401 66,765
Treasury stock (16,552) (12,013) (9,514)
Retained earnings 101,078 99,398 72,563
Accumulated other comprehensive loss (12,427) (10,667) (11,595)
Total stockholders’ equity 145,732 147,267 118,366
Total liabilities and stockholders’ equity 369,896 384,702 343,377
Class A Common stock      
Stockholders’ equity      
Common stock 114 112 111
Class B Common stock      
Stockholders’ equity      
Common stock $ 36 $ 36 $ 36
v3.24.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2023
Statement of Financial Position [Abstract]      
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01
v3.24.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenue $ 156,240 $ 137,109 $ 284,517 $ 265,361
Cost of sales 115,744 109,693 213,967 217,035
Gross profit 40,496 27,416 70,550 48,326
Selling, general and administrative expenses 30,397 26,640 61,344 52,559
Amortization of intangible assets 143 50 193 100
Operating profit (loss) 9,956 726 9,013 (4,333)
Interest expense, net 115 773 271 2,042
Other expense (income), net 883 (271) 1,056 (255)
Income (loss) before income taxes 8,958 224 7,686 (6,120)
Income tax expense (benefit) 2,972 114 2,862 (1,453)
Net income (loss) $ 5,986 $ 110 $ 4,824 $ (4,667)
Basic earnings (loss) per share (in dollars per share) $ 0.42 $ 0.01 $ 0.34 $ (0.33)
Diluted earnings (loss) per share (in dollars per share) $ 0.42 $ 0.01 $ 0.34 $ (0.33)
Basic weighted average shares outstanding (in shares) 14,113 14,081 14,137 14,077
Diluted weighted average shares outstanding (in shares) 14,127 14,110 14,152 14,077
v3.24.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ 5,986 $ 110 $ 4,824 $ (4,667)
Other comprehensive income (loss), net of tax:        
Foreign currency translation adjustment (1,868) 410 (2,965) 479
(Loss) gain on long-term intra-entity foreign currency transactions 0 201 0 653
Cash flow hedging activity 1,555 (25) 1,592 (1,462)
Reclassification of hedging activities into earnings (991) 342 (519) 529
Reclassification of pension adjustments into earnings 61 60 132 124
Total other comprehensive income (loss), net of tax (1,243) 988 (1,760) 323
Comprehensive income (loss) $ 4,743 $ 1,098 $ 3,064 $ (4,344)
v3.24.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net income (loss) $ 4,824 $ (4,667)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:    
Depreciation and amortization 2,628 2,128
Stock compensation expense 3,084 1,759
Other 1,610 (611)
Net changes in operating assets and liabilities:    
Trade receivables 49,582 26,393
Inventory (7,657) 20,390
Other assets (2,622) 396
Accounts payable (3,076) 22,240
Other liabilities (11,302) (10,768)
Net cash provided by (used for) operating activities 37,071 57,260
Investing activities    
Expenditures for property, plant and equipment (1,540) (1,486)
Acquisition of business, net of cash acquired (7,412) 0
Issuance of secured loan (600) 0
Repayment of secured loan 2,205 0
Other 0 (150)
Net cash provided by (used for) investing activities (7,347) (1,636)
Financing activities    
Net additions (reductions) to revolving credit agreements 0 (51,058)
Purchase of treasury stock (4,539) (575)
Cash dividends paid (3,144) (3,008)
Net cash provided by (used for) financing activities (7,683) (54,641)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (252) 182
Cash, cash equivalents and restricted cash    
Increase (decrease) for the period 21,789 1,165
Balance at the beginning of the period 16,379 1,905
Balance at the end of the period 38,168 3,070
Reconciliation of cash, cash equivalents and restricted cash    
Cash and cash equivalents 37,213 2,071
Restricted cash included in prepaid expenses and other current assets 50 63
Restricted cash included in other non-current assets 905 936
Total cash, cash equivalents and restricted cash $ 38,168 $ 3,070
v3.24.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Class A Common stock
Common Stock
Class B Common stock
Capital in Excess of Par Value
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022 $ 124,534 $ 107 $ 38 $ 65,008 $ (8,939) $ 80,238 $ (11,918)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (4,777)         (4,777)  
Issuance of common stock, net of conversions 0 4 (2) (2)      
Share-based compensation expense 797     797      
Cash dividends (1,460)         (1,460)  
Other comprehensive income (loss), net of tax (916)           (916)
Reclassification adjustment to net income (loss) 251           251
Ending balance at Mar. 31, 2023 118,429 111 36 65,803 (8,939) 74,001 (12,583)
Beginning balance at Dec. 31, 2022 124,534 107 38 65,008 (8,939) 80,238 (11,918)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (4,667)            
Ending balance at Jun. 30, 2023 118,366 111 36 66,765 (9,514) 72,563 (11,595)
Beginning balance at Mar. 31, 2023 118,429 111 36 65,803 (8,939) 74,001 (12,583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 110         110  
Purchase of treasury stock (575)       (575)    
Share-based compensation expense 962     962      
Cash dividends (1,548)         (1,548)  
Other comprehensive income (loss), net of tax 586           586
Reclassification adjustment to net income (loss) 402           402
Ending balance at Jun. 30, 2023 118,366 111 36 66,765 (9,514) 72,563 (11,595)
Beginning balance at Dec. 31, 2023 147,267 112 36 70,401 (12,013) 99,398 (10,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (1,162)         (1,162)  
Purchase of treasury stock (554)       (554)    
Issuance of common stock, net of conversions 0 2   (2)      
Share-based compensation expense 1,904     1,904      
Cash dividends (1,531)         (1,531)  
Other comprehensive income (loss), net of tax (1,060)           (1,060)
Reclassification adjustment to net income (loss) 543           543
Ending balance at Mar. 31, 2024 145,407 114 36 72,303 (12,567) 96,705 (11,184)
Beginning balance at Dec. 31, 2023 147,267 112 36 70,401 (12,013) 99,398 (10,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 4,824            
Ending balance at Jun. 30, 2024 145,732 114 36 73,483 (16,552) 101,078 (12,427)
Beginning balance at Mar. 31, 2024 145,407 114 36 72,303 (12,567) 96,705 (11,184)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 5,986         5,986  
Purchase of treasury stock (3,985)       (3,985)    
Share-based compensation expense 1,180     1,180      
Cash dividends (1,613)         (1,613)  
Other comprehensive income (loss), net of tax (313)           (313)
Reclassification adjustment to net income (loss) (930)           (930)
Ending balance at Jun. 30, 2024 $ 145,732 $ 114 $ 36 $ 73,483 $ (16,552) $ 101,078 $ (12,427)
v3.24.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) - $ / shares
3 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]        
Cash dividends (in dollars per share) $ 0.115 $ 0.11 $ 0.11 $ 0.105
v3.24.2
Basis of Presentation and Recently Issued Accounting Standards
6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Recently Issued Accounting Standards Basis of Presentation and Recently Issued Accounting Standards
Basis of Presentation

Throughout this Quarterly Report on Form 10-Q and the notes to unaudited consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”). HBB is the Company’s single reportable segment.

We are a leading designer, marketer and distributor of a wide range of branded small electric household and specialty housewares appliances, as well as commercial products for restaurants, fast food chains, bars and hotels, and are a provider of connected devices and software for healthcare management.

The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Operating results for the six months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the remainder of the year due to the highly seasonal nature of the Company’s primary markets. A majority of revenue and operating profit typically occurs in the second half of the calendar year when sales of products to retailers and consumers historically increase significantly for the fall holiday-selling season.

We maintain a $150.0 million senior secured floating-rate revolving credit facility (the “HBB Facility”) that expires on June 30, 2025, within one year after the issuance of these financial statements. Given the market conditions including unfavorable pricing terms, we have not yet completed our refinancing of the HBB Facility and accordingly, all amounts outstanding have been classified as current liabilities. Based on the current status of the refinancing and our history of successfully refinancing our debt, we believe that it is probable that the HBB Facility will be refinanced before its maturity. We believe funds available from cash on hand, the HBB Facility and operating cash flows will provide sufficient liquidity to meet our operating needs and commitments arising during the next twelve months.

Accounting Standards Not Yet Adopted

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which updates reportable segment disclosure requirements on an annual and interim basis. The amendments are effective for the annual period ending December 31, 2024, and the interim periods thereafter. Early adoption is permitted. Updates should be applied retrospectively to all prior periods presented in the financial statements. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which enhances income tax disclosure requirements primarily involving more detailed disclosure for income taxes paid and the effective tax rate reconciliation. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied prospectively but retrospective application is permitted. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows.
U.S. Pension Plan Termination

During 2022, the Board approved the termination of our U.S. defined benefit pension plan (the “Plan”) with an effective date of September 30, 2022. Benefit obligations under the Plan will be settled through a combination of lump sum payments to eligible plan participants and the purchase of a group annuity contract, under which future benefit obligations will be transferred to a third-party insurance company. The Company currently expects that all surplus assets remaining after the Plan termination will be transferred to a qualified replacement plan. The surplus assets as of December 31, 2023 were $12.2 million. The deferred loss of $6.5 million as of June 30, 2024 within Accumulated Other Comprehensive Income will be recognized fully when the plan is terminated or as settlements occur, which would trigger accelerated recognition. The termination process is expected to be completed in the third quarter of 2024.

Accounts payable - Supplier Finance Program
The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements. The agreement has a limit of $60.0 million in payment obligations ($85.0 million during peak season from August to January). There is no requirement to provide assets pledged as security or other forms of guarantees under the agreement. The Company pays the third-party administrator based upon the original payment terms negotiated with participating suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Consolidated Statement of Cash Flows. As of June 30, 2024, December 31, 2023 and June 30, 2023, the Company has $56.5 million, $55.0 million and $48.8 million, respectively, in outstanding payment obligations that are presented in Accounts payable on the Consolidated Balance Sheets. Of these totals, the third-party financial institution has made payments to participating suppliers to settle $48.0 million, $48.9 million and $44.9 million, respectively, of our outstanding payment obligations.
v3.24.2
Transfer of Financial Assets
6 Months Ended
Jun. 30, 2024
Transfers and Servicing [Abstract]  
Transfer of Financial Assets Transfer of Financial Assets
The Company has entered into an arrangement with a financial institution to sell certain U.S. trade receivables on a non-recourse basis. Under the terms of the agreement, the Company receives cash proceeds and retains no rights or interest and has no obligations with respect to the sold receivables. These transactions, which are accounted for as sold receivables, result in a reduction in trade receivables because the agreement transfers effective control over and risk related to the receivables to the buyer. Under this arrangement, the Company derecognized $40.5 million and $70.6 million of trade receivables during the three and six months ending June 30, 2024, respectively, $29.6 million and $59.3 million of trade receivables during the three and six months ending June 30, 2023, respectively, and $128.7 million during the year ending December 31, 2023. The loss incurred on sold receivables in the consolidated results of operations for the three and six months ended June 30, 2024 and 2023 was not material. The Company does not carry any servicing assets or liabilities. Cash proceeds from this arrangement are reflected as operating activities in the Consolidated Statements of Cash Flows.
v3.24.2
Fair Value Disclosure
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Disclosure Fair Value Disclosure
The following table presents the Company’s assets and liabilities accounted for at fair value on a recurring basis:
DescriptionBalance Sheet LocationJUNE 30
2024
 DECEMBER 31
2023
JUNE 30
2023
Assets:
Interest rate swap agreements
CurrentPrepaid expenses and other current assets$1,169 $511 $1,067 
Long-termOther non-current assets3,442 3,501 4,153 
Foreign currency exchange contracts
CurrentPrepaid expenses and other current assets325 — — 
$4,936 $4,012 $5,220 
Liabilities:
Foreign currency exchange contracts
CurrentOther current liabilities 538 807 
$ $538 $807 

The Company measures its derivatives at fair value using significant observable inputs, which is Level 2 as defined in the fair value hierarchy. The Company uses a present value technique that incorporates the Secured Overnight Financing Rate (SOFR) swap curve, foreign currency spot rates and foreign currency forward rates to value its derivatives, including its interest rate swap agreements and foreign currency exchange contracts. The Company also incorporates the effect of HBB and counterparty credit risk into the valuation.

Other Fair Value Measurement Disclosures

The carrying amounts of cash and cash equivalents, trade receivables and accounts payable approximate fair value due to the short-term maturities of these instruments.

The $150.0 million fair value of the HBB Facility, including book overdrafts, which approximate book value, was determined using current rates offered for similar obligations taking into account the Company’s credit risk, which is Level 2 as defined in the fair value hierarchy.

There were no transfers into or out of Levels 1, 2 or 3 during the three and six months ended June 30, 2024.
v3.24.2
Stockholders’ Equity
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Stockholders’ Equity Stockholders’ Equity
Capital Stock 

The following table sets forth the Company’s authorized capital stock information:
JUNE 30
2024
DECEMBER 31
2023
JUNE 30
2023
Preferred stock, par value $0.01 per share
Preferred stock authorized5,000 5,000 5,000 
Preferred stock outstanding — — 
Class A Common stock, par value $0.01 per share
Class A Common authorized70,000 70,000 70,000 
Class A Common issued (1)(2)
11,442 11,161 11,094 
Treasury Stock (3)
1,127 877 683 
Class B Common stock, par value $0.01 per share, convertible into Class A Common stock on a one-for-one basis
Class B Common authorized30,000 30,000 30,000 
Class B Common issued (1)
3,611 3,616 3,629 

(1) Class B Common converted to Class A Common were 1 and 5 shares during the three and six months ending June 30, 2024, respectively, and 0 and 215 during the three and six months ending June 30, 2023, respectively.

(2) The Company issued Class A Common of 14 and 276 shares during the three and six months ending June 30, 2024, respectively, and 24 and 216 during the three and six months ending June 30, 2023, respectively.

(3) On March 5, 2024, a total of 30 mandatory cashless-exercise-award shares of Class A Common were surrendered to the Company by the participants of our Executive Long-Term Equity Incentive Compensation Plan (the “Incentive Plan”) in order to satisfy the participants’ tax withholding obligations with respect to shares of Class A Common awarded under the Incentive Plan on March 5, 2024.

Stock Repurchase Program: In November 2023, the Company’s Board approved a stock repurchase program for the purchase of up to $25 million of the Company’s Class A Common outstanding starting January 1, 2024 and ending December 31, 2025. This program replaced the previous stock repurchase plan that started February 22, 2022 and ended December 31, 2023. During the three and six months ended June 30, 2024, the Company repurchased 220,212 shares at prevailing market prices for an aggregate purchase price of $4.0 million. During the three and six months ended June 30, 2023, the Company repurchased 56,973 shares at prevailing market prices for an aggregate purchase price of $0.6 million. During the year ended December 31, 2023, the Company repurchased 250,772 shares for an aggregate purchase price of $3.1 million. As of June 30, 2024, the Company had $21.0 million remaining authorized for repurchase.
Accumulated Other Comprehensive Loss: The following table summarizes changes in accumulated other comprehensive loss by component and related tax effects for periods shown:
 Foreign CurrencyDeferred Gain (Loss) on Cash Flow Hedging Pension Plan AdjustmentTotal
Balance, January 1, 2024$(6,412)$2,424 $(6,679)$(10,667)
Other comprehensive income (loss)(1,097)29  (1,068)
Reclassification adjustment to net income (loss) 647 94 741 
Tax effects (167)(23)(190)
Balance, March 31, 2024(7,509)2,933 (6,608)(11,184)
Other comprehensive income (loss)(1,868)2,104  236 
Reclassification adjustment to net income (loss) (1,325)83 (1,242)
Tax effects (215)(22)(237)
Balance, June 30, 2024$(9,377)$3,497 $(6,547)$(12,427)
Balance, January 1, 2023$(8,924)$4,158 $(7,152)$(11,918)
Other comprehensive income (loss)715 (1,881)— (1,166)
Reclassification adjustment to net income (loss)— 252 87 339 
Tax effects(194)379 (23)162 
Balance, March 31, 2023(8,403)2,908 (7,088)(12,583)
Other comprehensive income (loss)425 (59)— 366 
Reclassification adjustment to net income (loss)— 465 83 548 
Tax effects186 (89)(23)74 
Balance, June 30, 2023$(7,792)$3,225 $(7,028)$(11,595)
v3.24.2
Revenue
6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services, which includes an estimate for variable consideration.

The Company’s warranty program to the consumer consists generally of an assurance-type limited warranty lasting for varying periods of up to ten years for electric appliances, with the majority of products having a warranty of one to three years. There is no guarantee to the consumer as the Company may repair or replace, in its discretion, products returned under warranty. Accordingly, the Company determined that no separate performance obligation exists.

Most of the Company’s products are not sold with a general right of return. Subject to certain terms and conditions, however, the Company will agree to accept a portion of products sold that, based on historical experience, are estimated to be returned for reasons such as product failure and excess inventory stocked by the customer. Product returns, customer programs and incentive offerings, including special pricing agreements, price competition, promotions and other volume-based incentives are accounted for as variable consideration.
A description of revenue sources and performance obligations for the Company are as follows:

Consumer and Commercial product revenue
Transactions with both consumer and commercial customers generally originate upon the receipt of a purchase order from a customer, which in some cases are governed by master sales agreements, specifying product(s) that the customer desires. Contracts for product revenue have an original duration of one year or less, and payment terms are generally standard and based on customer creditworthiness. Revenue from product sales is recognized at the point in time when control transfers to the customer, which is either when a product is shipped from a Company facility, or delivered to customers, depending on the shipping terms. The amount of revenue recognized varies primarily with price concessions and changes in returns. The Company offers price concessions to its customers for incentive offerings, special pricing agreements, price competition, promotions or other volume-based arrangements. The Company evaluated such agreements with its customers and determined returns and price concessions should be accounted for as variable consideration.

Consumer product revenue consists of sales of small electric household and specialty housewares appliances to traditional brick and mortar and ecommerce retailers, distributors and directly to the end consumer. A majority of this revenue is in North America.

Commercial product revenue consists of sales of products for restaurants, fast-food chains, bars and hotels. Approximately one-half of the Company’s commercial sales is in the U.S. and the other half is in markets across the globe.

License revenue
From time to time, the Company enters into exclusive and non-exclusive licensing agreements which grant the right to use certain of the Company’s intellectual property (“IP”) in connection with designing, manufacturing, distributing, advertising, promoting and selling the licensees’ products during the term of the agreement. The IP that is licensed generally consists of trademarks, trade names, patents, trade dress, logos and/or products (the “Licensed IP”). In exchange for granting the right to use the Licensed IP, the Company receives a royalty payment, which is a function of (1) the total net sales of products that use the Licensed IP and (2) the royalty percentage that is stated in the licensing agreement. The Company recognizes revenue at the later of when the subsequent sales occur or when the performance obligation is satisfied over time. Additionally, the Company enters into agreements which grant the right to use software for healthcare management. The Company receives a license payment which is recognized when the performance obligation is satisfied over time.

Lease revenue
The Company leases connected devices to specialty pharmacy networks and pharmaceutical companies and is accounted for under Accounting Standards Codification 842, Leases as operating leases.

The following table sets forth Company’s revenue on a disaggregated basis for the three and six months ended June 30:
THREE MONTHS ENDED
JUNE 30
SIX MONTHS ENDED
JUNE 30
 2024 202320242023
Type of good or service:
  Consumer products$139,785 $122,561 $252,535 $235,993 
  Commercial products14,420 13,671 27,873 27,075 
  Licensing1,345 877 2,960 2,293 
  Leasing690 — 1,149 — 
     Total revenues$156,240 $137,109 $284,517 $265,361 
v3.24.2
Contingencies
6 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
The Company is involved in various legal and regulatory proceedings and claims that have arisen in the ordinary course of business, including product liability, patent infringement, asbestos related claims, environmental and other claims. Although it is difficult to predict the ultimate outcome of these proceedings and claims, the Company believes the ultimate disposition of these matters will not have a material adverse effect on the financial condition, results of operation or cash flows of the Company. Any costs that the Company estimates will be paid as a result of these claims are accrued when the liability is considered probable and the amount of such costs can be reasonably estimated. If a range of amounts can be reasonably estimated and no amount within the range is a better estimate than any other amount, then the minimum of the range is accrued.
The Company does not accrue liabilities when the likelihood that the liability has been incurred is probable but the amount cannot be reasonably estimated or when the liability is believed to be only reasonably possible or remote. For contingencies where an unfavorable outcome is probable or reasonably possible and which are material, the Company discloses the nature of the contingency and, in some circumstances, an estimate of the possible loss.

Proceedings and claims asserted against the Company are subject to inherent uncertainties and unfavorable rulings could occur. If an unfavorable ruling were to occur, there exists the possibility of an adverse impact on the Company’s financial position and on the results of operations and cash flows for the period in which the ruling occurs, or in future periods.

Environmental matters

The Company is investigating or remediating historical environmental contamination at some current and former sites operated by the Company or by businesses it acquired. Based on the current stage of the investigation or remediation at each known site, the Company estimates the total investigation and remediation costs and the period of assessment and remediation activity required for each site. The estimate of future investigation and remediation costs is primarily based on variables associated with site clean-up, including, but not limited to, physical characteristics of the site, the nature and extent of the contamination and applicable regulatory programs and remediation standards.
No assessment can fully characterize all subsurface conditions at a site. There is no assurance that additional assessment and remediation efforts will not result in adjustments to estimated remediation costs or the time frame for remediation at these sites.

The Company’s estimates of investigation and remediation costs may change if it discovers contamination at additional sites or additional contamination at known sites, if the effectiveness of its current remediation efforts change, if applicable federal or state regulations change or if the Company’s estimate of the time required to remediate the sites changes. The Company’s current estimates may differ materially from original estimates.        

As of June 30, 2024, December 31, 2023 and June 30, 2023, the Company had accrued undiscounted obligations of $3.2 million, $3.4 million and $3.5 million, respectively, for environmental investigation and remediation activities. The Company estimates that it is reasonably possible that it may incur additional expenses in the range of zero to $1.5 million related to the environmental investigation and remediation at these sites. As of June 30, 2024, the Company has $1.0 million, classified as restricted cash, associated with reimbursement of environmental investigation and remediation costs from a responsible party in exchange for release from all future obligations for one site. Additionally, the Company has a $1.2 million asset associated with the reimbursement of costs associated with two sites.
v3.24.2
Income Taxes
6 Months Ended
Jun. 30, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The Company’s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period.

The effective tax rate was 33.2% and 50.9% on income for the three months ended June 30, 2024 and 2023, respectively. The effective tax rate was lower in the three months ended June 30, 2024 due to a decrease in unfavorable discrete items, partially offset by a valuation allowance on foreign losses.

The effective tax rate was 37.2% on income and 23.7% on loss for the six months ended June 30, 2024 and 2023, respectively. The effective tax rate was higher for the six months ended June 30, 2024 due to a valuation allowance on foreign losses subject to a foreign statutory rate lower than the US tax rate.
v3.24.2
Acquisitions
6 Months Ended
Jun. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Acquisitions Acquisitions
On February 2, 2024, we completed the acquisition of HealthBeacon PLC (“HealthBeacon”), a medical technology firm and strategic partner of the Company, for €6.9 million (approximately $7.5 million). The transaction was funded with cash on hand.

The acquisition of HealthBeacon was accounted for as a business combination using the acquisition method of accounting. The results of operations for HealthBeacon are included in the accompanying Consolidated Statements of Operations from the acquisition date (February 2, 2024) until June 30, 2024. HealthBeacon had $0.8 million and $1.4 million in revenue and $1.5 million and $2.6 million in operating loss that was included in our consolidated financial statements for the three and six months ended June 30, 2024, respectively. Pro forma financial information has not been presented, as revenue and expenses related to the acquisition do not have a material impact on the Company’s unaudited consolidated financial statements.

The determination and allocation of purchase price consideration is based on preliminary estimates of fair value; such estimates and assumptions are subject to change within the measurement period (up to one year from the acquisition date). As of June 30, 2024, the purchase price allocation for HealthBeacon is preliminary as we assess and gather additional information regarding the fair value of the assets acquired and liabilities assumed as of the acquisition date. We may revise our preliminary estimates during the measurement period as third-party valuations are finalized, additional information becomes available and as additional analyses are performed. These differences could have a material impact on our results of operations and financial position.

The valuations of property, plant and equipment and intangible assets were updated in the second quarter of 2024. Property, plant, and equipment decreased by $0.8 million and intangible assets decreased by less than $0.1 million resulting in $0.8 million of goodwill.

During the three and six months ended June 30, 2024, we incurred transaction costs of approximately $0.1 million and $1.1 million, respectively, which are included in Selling, general and administrative expenses.

The following table presents the preliminary value of assets acquired and liabilities assumed and will be finalized pending completion of purchase accounting matters:
Preliminary Fair Values as of
February 2, 2024
Cash and cash equivalents$147 
Current assets1,452 
Property, plant and equipment, net6,634 
Goodwill847 
Other intangible assets, net1,111 
Total assets acquired10,191 
Liabilities, current2,016 
Liabilities, non-current616 
Total liabilities acquired2,632 
Purchase Price$7,559 
v3.24.2
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure            
Net income (loss) $ 5,986 $ (1,162) $ 110 $ (4,777) $ 4,824 $ (4,667)
v3.24.2
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.2
Basis of Presentation and Recently Issued Accounting Standards (Policies)
6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

Throughout this Quarterly Report on Form 10-Q and the notes to unaudited consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”). HBB is the Company’s single reportable segment.

We are a leading designer, marketer and distributor of a wide range of branded small electric household and specialty housewares appliances, as well as commercial products for restaurants, fast food chains, bars and hotels, and are a provider of connected devices and software for healthcare management.

The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Operating results for the six months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the remainder of the year due to the highly seasonal nature of the Company’s primary markets. A majority of revenue and operating profit typically occurs in the second half of the calendar year when sales of products to retailers and consumers historically increase significantly for the fall holiday-selling season.
Accounting Standards Not Yet Adopted
Accounting Standards Not Yet Adopted

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which updates reportable segment disclosure requirements on an annual and interim basis. The amendments are effective for the annual period ending December 31, 2024, and the interim periods thereafter. Early adoption is permitted. Updates should be applied retrospectively to all prior periods presented in the financial statements. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which enhances income tax disclosure requirements primarily involving more detailed disclosure for income taxes paid and the effective tax rate reconciliation. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied prospectively but retrospective application is permitted. Adoption of this ASU may result in additional disclosure, but it will not impact the Company’s consolidated financial position, results of operations or cash flows.
Accounts payable - Supplier Finance Program
Accounts payable - Supplier Finance Program
The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements. The agreement has a limit of $60.0 million in payment obligations ($85.0 million during peak season from August to January). There is no requirement to provide assets pledged as security or other forms of guarantees under the agreement. The Company pays the third-party administrator based upon the original payment terms negotiated with participating suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Consolidated Statement of Cash Flows.
v3.24.2
Fair Value Disclosure (Tables)
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table presents the Company’s assets and liabilities accounted for at fair value on a recurring basis:
DescriptionBalance Sheet LocationJUNE 30
2024
 DECEMBER 31
2023
JUNE 30
2023
Assets:
Interest rate swap agreements
CurrentPrepaid expenses and other current assets$1,169 $511 $1,067 
Long-termOther non-current assets3,442 3,501 4,153 
Foreign currency exchange contracts
CurrentPrepaid expenses and other current assets325 — — 
$4,936 $4,012 $5,220 
Liabilities:
Foreign currency exchange contracts
CurrentOther current liabilities 538 807 
$ $538 $807 
v3.24.2
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of Capital Stock
The following table sets forth the Company’s authorized capital stock information:
JUNE 30
2024
DECEMBER 31
2023
JUNE 30
2023
Preferred stock, par value $0.01 per share
Preferred stock authorized5,000 5,000 5,000 
Preferred stock outstanding — — 
Class A Common stock, par value $0.01 per share
Class A Common authorized70,000 70,000 70,000 
Class A Common issued (1)(2)
11,442 11,161 11,094 
Treasury Stock (3)
1,127 877 683 
Class B Common stock, par value $0.01 per share, convertible into Class A Common stock on a one-for-one basis
Class B Common authorized30,000 30,000 30,000 
Class B Common issued (1)
3,611 3,616 3,629 

(1) Class B Common converted to Class A Common were 1 and 5 shares during the three and six months ending June 30, 2024, respectively, and 0 and 215 during the three and six months ending June 30, 2023, respectively.

(2) The Company issued Class A Common of 14 and 276 shares during the three and six months ending June 30, 2024, respectively, and 24 and 216 during the three and six months ending June 30, 2023, respectively.

(3) On March 5, 2024, a total of 30 mandatory cashless-exercise-award shares of Class A Common were surrendered to the Company by the participants of our Executive Long-Term Equity Incentive Compensation Plan (the “Incentive Plan”) in order to satisfy the participants’ tax withholding obligations with respect to shares of Class A Common awarded under the Incentive Plan on March 5, 2024.
Schedule of Accumulated Other Comprehensive Loss The following table summarizes changes in accumulated other comprehensive loss by component and related tax effects for periods shown:
 Foreign CurrencyDeferred Gain (Loss) on Cash Flow Hedging Pension Plan AdjustmentTotal
Balance, January 1, 2024$(6,412)$2,424 $(6,679)$(10,667)
Other comprehensive income (loss)(1,097)29  (1,068)
Reclassification adjustment to net income (loss) 647 94 741 
Tax effects (167)(23)(190)
Balance, March 31, 2024(7,509)2,933 (6,608)(11,184)
Other comprehensive income (loss)(1,868)2,104  236 
Reclassification adjustment to net income (loss) (1,325)83 (1,242)
Tax effects (215)(22)(237)
Balance, June 30, 2024$(9,377)$3,497 $(6,547)$(12,427)
Balance, January 1, 2023$(8,924)$4,158 $(7,152)$(11,918)
Other comprehensive income (loss)715 (1,881)— (1,166)
Reclassification adjustment to net income (loss)— 252 87 339 
Tax effects(194)379 (23)162 
Balance, March 31, 2023(8,403)2,908 (7,088)(12,583)
Other comprehensive income (loss)425 (59)— 366 
Reclassification adjustment to net income (loss)— 465 83 548 
Tax effects186 (89)(23)74 
Balance, June 30, 2023$(7,792)$3,225 $(7,028)$(11,595)
v3.24.2
Revenue (Tables)
6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table sets forth Company’s revenue on a disaggregated basis for the three and six months ended June 30:
THREE MONTHS ENDED
JUNE 30
SIX MONTHS ENDED
JUNE 30
 2024 202320242023
Type of good or service:
  Consumer products$139,785 $122,561 $252,535 $235,993 
  Commercial products14,420 13,671 27,873 27,075 
  Licensing1,345 877 2,960 2,293 
  Leasing690 — 1,149 — 
     Total revenues$156,240 $137,109 $284,517 $265,361 
v3.24.2
Acquisitions (Tables)
6 Months Ended
Jun. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule of Preliminary Assets Acquired and Liabilities Assumed
The following table presents the preliminary value of assets acquired and liabilities assumed and will be finalized pending completion of purchase accounting matters:
Preliminary Fair Values as of
February 2, 2024
Cash and cash equivalents$147 
Current assets1,452 
Property, plant and equipment, net6,634 
Goodwill847 
Other intangible assets, net1,111 
Total assets acquired10,191 
Liabilities, current2,016 
Liabilities, non-current616 
Total liabilities acquired2,632 
Purchase Price$7,559 
v3.24.2
Basis of Presentation and Recently Issued Accounting Standards (Details) - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Basis of Presentation and Policies [Line Items]      
Surplus assets     $ 12.2
Deferred loss within accumulated other comprehensive income $ (6.5)    
Limit on payment obligations 60.0    
Outstanding payment obligations, current $ 56.5 $ 48.8 $ 55.0
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration] Accounts payable Accounts payable Accounts payable
Supplier finance program, obligation, settlement $ 48.0 $ 44.9 $ 48.9
Maximum      
Basis of Presentation and Policies [Line Items]      
Limit on payment obligations 85.0    
Letter of Credit | HBB Facility      
Basis of Presentation and Policies [Line Items]      
Line of credit facility, maximum borrowing capacity $ 150.0    
v3.24.2
Transfer of Financial Assets (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Transfers and Servicing [Abstract]          
Accounts receivable derecognized $ 40.5 $ 29.6 $ 70.6 $ 59.3 $ 128.7
Loss on sale of accounts receivable $ 0.0 $ 0.0 $ 0.0 $ 0.0  
v3.24.2
Fair Value Disclosure (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2023
Letter of Credit | HBB Facility      
Liabilities:      
Line of credit facility, maximum borrowing capacity $ 150,000    
Fair value measurements, recurring      
Assets:      
Assets at fair value 4,936 $ 4,012 $ 5,220
Liabilities:      
Liabilities at fair value 0 538 807
Fair value measurements, recurring | Prepaid expenses and other current assets      
Assets:      
Interest rate swap agreements 1,169 511 1,067
Foreign currency exchange contracts 325 0 0
Fair value measurements, recurring | Other non-current assets      
Assets:      
Interest rate swap agreements 3,442 3,501 4,153
Fair value measurements, recurring | Other current liabilities      
Liabilities:      
Foreign currency exchange contracts $ 0 $ 538 $ 807
v3.24.2
Stockholders’ Equity - Schedule of Capital Stock (Details)
shares in Thousands
3 Months Ended 6 Months Ended
Mar. 05, 2024
shares
Jun. 30, 2024
$ / shares
shares
Jun. 30, 2023
$ / shares
shares
Jun. 30, 2024
$ / shares
shares
Jun. 30, 2023
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Class of Stock [Line Items]            
Preferred stock, par value (in dollars per share) | $ / shares   $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Preferred stock authorized (in shares)   5,000 5,000 5,000 5,000 5,000
Preferred stock outstanding (in shares)   0 0 0 0 0
Class A Common stock            
Class of Stock [Line Items]            
Common stock, par value (in dollars per share) | $ / shares   $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Common stock authorized (in shares)   70,000 70,000 70,000 70,000 70,000
Common stock issued (in shares)   11,442 11,094 11,442 11,094 11,161
Treasury Stock (in shares)   1,127 683 1,127 683 877
Class A common shares issued (in shares)   14 24 276 216  
Class A Common stock | Incentive Plan            
Class of Stock [Line Items]            
Number of shares surrendered to satisfy tax withholding obligation 30          
Class B Common stock            
Class of Stock [Line Items]            
Common stock, par value (in dollars per share) | $ / shares   $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Common stock, convertible conversion ratio   1 1 1 1 1
Common stock authorized (in shares)   30,000 30,000 30,000 30,000 30,000
Common stock issued (in shares)   3,611 3,629 3,611 3,629 3,616
Class B common converted to Class A common (in shares)   1 0 5 215  
v3.24.2
Stockholders’ Equity - Stock Repurchase Program (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Nov. 30, 2023
Class of Stock [Line Items]            
Stock repurchased (in shares) 220,212 56,973 220,212 56,973 250,772  
Aggregate purchase price $ 4.0 $ 0.6 $ 4.0 $ 0.6 $ 3.1  
Remaining authorized repurchase amount $ 21.0   $ 21.0      
Shares Outstanding Class A            
Class of Stock [Line Items]            
Stock repurchase program, number of shares authorized to be repurchased (in shares)           25,000,000
v3.24.2
Stockholders’ Equity - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance $ 145,407 $ 147,267 $ 118,429 $ 124,534
Other comprehensive income (loss) 236 (1,068) 366 (1,166)
Reclassification adjustment to net income (loss) (1,242) 741 548 339
Tax effects (237) (190) 74 162
Ending balance 145,732 145,407 118,366 118,429
Accumulated Other Comprehensive Income (Loss)        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (11,184) (10,667) (12,583) (11,918)
Ending balance (12,427) (11,184) (11,595) (12,583)
Foreign Currency        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (7,509) (6,412) (8,403) (8,924)
Other comprehensive income (loss) (1,868) (1,097) 425 715
Reclassification adjustment to net income (loss) 0 0 0 0
Tax effects 0 0 186 (194)
Ending balance (9,377) (7,509) (7,792) (8,403)
Deferred Gain (Loss) on Cash Flow Hedging        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance 2,933 2,424 2,908 4,158
Other comprehensive income (loss) 2,104 29 (59) (1,881)
Reclassification adjustment to net income (loss) (1,325) 647 465 252
Tax effects (215) (167) (89) 379
Ending balance 3,497 2,933 3,225 2,908
Pension Plan Adjustment        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (6,608) (6,679) (7,088) (7,152)
Other comprehensive income (loss) 0 0 0 0
Reclassification adjustment to net income (loss) 83 94 83 87
Tax effects (22) (23) (23) (23)
Ending balance $ (6,547) $ (6,608) $ (7,028) $ (7,088)
v3.24.2
Revenue - Narrative (Details)
6 Months Ended
Jun. 30, 2024
Commercial products | Geographic Concentration Risk | Revenue from Contract with Customer Benchmark | United States  
Disaggregation of Revenue [Line Items]  
Concentration risk, percentage 50.00%
Commercial products | Geographic Concentration Risk | Revenue from Contract with Customer Benchmark | Non-US  
Disaggregation of Revenue [Line Items]  
Concentration risk, percentage 50.00%
Maximum | Electric appliances  
Disaggregation of Revenue [Line Items]  
Warranty term 10 years
Maximum | Other products  
Disaggregation of Revenue [Line Items]  
Warranty term 3 years
Maximum | Consumer products  
Disaggregation of Revenue [Line Items]  
Revenue contract duration 1 year
Maximum | Commercial products  
Disaggregation of Revenue [Line Items]  
Revenue contract duration 1 year
Minimum | Other products  
Disaggregation of Revenue [Line Items]  
Warranty term 1 year
v3.24.2
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Disaggregation of Revenue [Line Items]        
Leasing $ 690 $ 0 $ 1,149 $ 0
Total revenues 156,240 137,109 284,517 265,361
Consumer products        
Disaggregation of Revenue [Line Items]        
Revenue 139,785 122,561 252,535 235,993
Commercial products        
Disaggregation of Revenue [Line Items]        
Revenue 14,420 13,671 27,873 27,075
Licensing        
Disaggregation of Revenue [Line Items]        
Revenue $ 1,345 $ 877 $ 2,960 $ 2,293
v3.24.2
Contingencies (Details)
$ in Millions
6 Months Ended
Jun. 30, 2024
USD ($)
numberOfSite
Dec. 31, 2023
USD ($)
Jun. 30, 2023
USD ($)
Loss Contingencies [Line Items]      
Accrual for environmental investigation and remediation activities $ 3.2 $ 3.4 $ 3.5
Portion of loss contingency proceeds representing restricted cash 1.0    
Asset associated with reimbursement of costs $ 1.2    
Loss contingency, number of sites associated with cost reimbursement | numberOfSite 2    
Minimum      
Loss Contingencies [Line Items]      
Estimate of additional expenses $ 0.0    
Maximum      
Loss Contingencies [Line Items]      
Estimate of additional expenses $ 1.5    
v3.24.2
Income Taxes (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Tax Disclosure [Abstract]        
Effective tax rate 33.20% 50.90% 37.20% 23.70%
v3.24.2
Acquisitions - Narrative (Details)
$ in Thousands, € in Millions
3 Months Ended 6 Months Ended
Feb. 02, 2024
USD ($)
Feb. 02, 2024
EUR (€)
Jun. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Jun. 30, 2023
USD ($)
Asset Acquisition [Line Items]            
Goodwill     $ 7,099 $ 7,099 $ 6,253 $ 6,253
HealthBeacon            
Asset Acquisition [Line Items]            
Business combination, consideration transferred $ 7,500 € 6.9        
Revenues     800 1,400    
Operating loss     1,500 2,600    
Decrease in property, plant and equipment     800      
Decrease in intangible assets (less than)     100      
Goodwill $ 847   800 800    
Transaction costs     $ 100 $ 1,100    
v3.24.2
Acquisitions - Schedule of Preliminary Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Feb. 02, 2024
Dec. 31, 2023
Jun. 30, 2023
Asset Acquisition [Line Items]        
Goodwill $ 7,099   $ 6,253 $ 6,253
HealthBeacon        
Asset Acquisition [Line Items]        
Cash and cash equivalents   $ 147    
Current assets   1,452    
Property, plant and equipment, net   6,634    
Goodwill $ 800 847    
Other intangible assets, net   1,111    
Total assets acquired   10,191    
Liabilities, current   2,016    
Liabilities, non-current   616    
Total liabilities acquired   2,632    
Purchase Price   $ 7,559    

Hamilton Beach Brands (NYSE:HBB)
過去 株価チャート
から 7 2024 まで 8 2024 Hamilton Beach Brandsのチャートをもっと見るにはこちらをクリック
Hamilton Beach Brands (NYSE:HBB)
過去 株価チャート
から 8 2023 まで 8 2024 Hamilton Beach Brandsのチャートをもっと見るにはこちらをクリック